방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 피부과 삶의 질 지수× | 파킨슨병 설문지-39 (Parkinson's Disease Questionnaire-39)× | |
|---|---|---|
| 분야 | 건강 결과 | 건강 결과 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 1994 | 1997 |
| 창시자≠ | Andrew Y. Finlay and Gul K. Khan | Crispin Jenkinson et al. |
| 유형 | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| 원전≠ | Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210-216. DOI ↗ | Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26(5), 353-357. DOI ↗ |
| 별칭 | DLQI, Finlay Index, Dermatology Quality of Life | PDQ-39, Parkinson's Disease Questionnaire, PDQ |
| 관련≠ | 3 | 4 |
| 요약≠ | The DLQI is the primary patient-centered outcome measure in dermatology research and clinical practice. Developed by Andrew Finlay and Gul Khan in 1994, this 10-item self-report questionnaire quantifies the impact of skin disease on patients' daily functioning, emotional well-being, social relationships, and work capacity. It is simple, rapid, and applicable to virtually all dermatological conditions, making it the gold standard for assessing quality of life in dermatology. | The PDQ-39 is the most widely used patient-reported outcome measure for Parkinson's disease quality of life. Developed by Crispin Jenkinson and colleagues in 1997, this 39-item self-report questionnaire comprehensively assesses how Parkinson's symptoms affect daily functioning, emotional well-being, stigma, social support, and cognitive-communication abilities. It is the recommended instrument in major Parkinson's disease clinical trials and forms a core component of outcome measurement in movement disorders. |
| ScholarGate데이터셋 ↗ |
|
|